Precipio Past Earnings Performance
Past criteria checks 0/6
Precipio has been growing earnings at an average annual rate of 16.8%, while the Healthcare industry saw earnings growing at 15.3% annually. Revenues have been growing at an average rate of 30.4% per year.
Key information
16.8%
Earnings growth rate
78.0%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 30.4% |
| Return on equity | -69.7% |
| Net Margin | -68.4% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Precipio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 13 | -9 | 14 | 0 |
| 30 Jun 23 | 11 | -11 | 14 | 0 |
| 31 Mar 23 | 10 | -11 | 14 | 0 |
| 31 Dec 22 | 9 | -12 | 15 | 0 |
| 30 Sep 22 | 9 | -12 | 16 | 0 |
| 30 Jun 22 | 9 | -11 | 15 | 0 |
| 31 Mar 22 | 9 | -12 | 15 | 0 |
| 31 Dec 21 | 9 | -9 | 12 | 0 |
| 30 Sep 21 | 8 | -8 | 11 | 0 |
| 30 Jun 21 | 8 | -10 | 11 | 0 |
| 31 Mar 21 | 7 | -9 | 11 | 0 |
| 31 Dec 20 | 6 | -14 | 10 | 0 |
| 30 Sep 20 | 5 | -16 | 10 | 0 |
| 30 Jun 20 | 4 | -14 | 10 | 0 |
| 31 Mar 20 | 4 | -18 | 10 | 0 |
| 31 Dec 19 | 3 | -13 | 10 | 0 |
| 30 Sep 19 | 3 | -16 | 9 | 0 |
| 30 Jun 19 | 3 | -18 | 9 | 0 |
| 31 Mar 19 | 3 | -16 | 9 | 0 |
| 31 Dec 18 | 3 | -20 | 9 | 0 |
| 30 Sep 18 | 3 | -26 | 10 | 0 |
| 30 Jun 18 | 3 | -33 | 10 | 0 |
| 31 Mar 18 | 2 | -38 | 8 | 0 |
| 31 Dec 17 | 2 | -33 | 6 | 0 |
| 30 Sep 17 | 1 | -21 | 5 | 0 |
| 30 Jun 17 | 1 | -11 | 3 | 0 |
| 31 Mar 17 | 1 | -3 | 3 | 0 |
| 31 Dec 16 | 2 | -4 | 2 | 0 |
| 31 Dec 15 | 1 | -2 | 2 | 0 |
Quality Earnings: TGK is currently unprofitable.
Growing Profit Margin: TGK is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TGK is unprofitable, but has reduced losses over the past 5 years at a rate of 16.8% per year.
Accelerating Growth: Unable to compare TGK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TGK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.1%).
Return on Equity
High ROE: TGK has a negative Return on Equity (-69.69%), as it is currently unprofitable.